Zhou, J., An, G., Liu, Y., Yan, W., Du, C., Deng, S., Sui, W., Xu, Y., Qiu, L. (2025). Ixazomib combined with daratumumab-based regimens as first-line therapy for transplant-ineligible patients with newly diagnosed multiple myeloma: A real-world historical database analysis from China. Blood. https://doi.org/10.1182/blood-2025-8142